Cargando…

Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease

BACKGROUND: Chronic ingestion of ethanol increases acetaldehyde and leads to the production of acetaldehyde-derived advanced glycation end-products (AA-AGE). We evaluated the toxicity of AA-AGE on hepatocytes and studied the role of AA-AGE in the pathogenesis of alcoholic liver disease (ALD). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashi, Nobuhiko, George, Joseph, Takeuchi, Masayoshi, Fukumura, Atsushi, Toshikuni, Nobuyuki, Arisawa, Tomiyasu, Tsutsumi, Mikihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724722/ https://www.ncbi.nlm.nih.gov/pubmed/23922897 http://dx.doi.org/10.1371/journal.pone.0070034

Ejemplares similares

Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia
por: Toshikuni, Nobuyuki, et al.
Publicado: (2013)

Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis
por: Toshikuni, Nobuyuki, et al.
Publicado: (2017)

Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma
por: Toshikuni, Nobuyuki, et al.
Publicado: (2013)

Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection
por: Matsue, Yasuhiro, et al.
Publicado: (2015)

Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol
por: Yamada, Masayoshi, et al.
Publicado: (2011)

Serum Endocan as a Novel Prognostic Biomarker in Patients with Hepatocellular Carcinoma
por: Ozaki, Kazuaki, et al.
Publicado: (2014)

The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people
por: KINOSHITA, Kaori, et al.
Publicado: (2019)

An Image Fusion System for Estimating the Therapeutic Effects of Radiofrequency Ablation on Hepatocellular Carcinoma
por: Toshikuni, Nobuyuki, et al.
Publicado: (2017)

Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa
por: Arisawa, Tomiyasu, et al.
Publicado: (2012)

Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver
por: Takata, Takanobu, et al.
Publicado: (2019)

Mystic Acetaldehyde: The Never-Ending Story on Alcoholism
por: Peana, Alessandra T., et al.
Publicado: (2017)

Acetaldehyde adducts in alcoholic liver disease
por: Setshedi, Mashiko, et al.
Publicado: (2010)

Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease
por: Sueyoshi, Shigeo, et al.
Publicado: (2016)

Cancer Malignancy Is Enhanced by Glyceraldehyde-Derived Advanced Glycation End-Products
por: Takino, Jun-Ichi, et al.
Publicado: (2010)

Neuropathy induced by exogenously administered advanced glycation end‐products in rats
por: Nishizawa, Yusuke, et al.
Publicado: (2010)

Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
por: Takata, Takanobu, et al.
Publicado: (2019)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
por: Takata, Takanobu, et al.
Publicado: (2020)

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
por: Leung, Christopher, et al.
Publicado: (2016)

Intracellular Toxic Advanced Glycation End-Products May Induce Cell Death and Suppress Cardiac Fibroblasts
por: Takata, Takanobu, et al.
Publicado: (2022)

Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2017)

Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion
por: Takata, Takanobu, et al.
Publicado: (2017)

Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products
por: Fernando, Dinali H., et al.
Publicado: (2019)

Autofluorescence as a noninvasive biomarker of senescence and advanced glycation end products in Caenorhabditis elegans
por: Komura, Tomomi, et al.
Publicado: (2021)

Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2020)

Glyceraldehyde-Derived Advanced Glycation End Products Accumulate Faster Than N(ε)-(Carboxymethyl) Lysine
por: Yokota, Mami, et al.
Publicado: (2017)

Advanced Glycation End Product Accumulation in Subjects with Open-Angle Glaucoma with and without Exfoliation
por: Shirakami, Tomoki, et al.
Publicado: (2020)

The Association between Accumulation of Toxic Advanced Glycation End-Products and Cytotoxic Effect in MC3T3-E1 Cells
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2022)

Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan
por: Takeuchi, Masayoshi, et al.
Publicado: (2015)

Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model
por: Inoue, Shinya, et al.
Publicado: (2020)

Experimental Assessment of the Role of Acetaldehyde in Alcoholic Cardiomyopathy
por: Aberle II, Nicholas S., et al.
Publicado: (2003)

Alcohol-Derived Acetaldehyde Exposure in the Oral Cavity
por: Stornetta, Alessia, et al.
Publicado: (2018)

Effect of Dietary Advanced Glycation End Products on Mouse Liver
por: Patel, Raza, et al.
Publicado: (2012)

Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium
por: Nomura, Tomoe, et al.
Publicado: (2013)

Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease
por: Pereira, Evelyn Nunes Goulart da Silva, et al.
Publicado: (2017)

Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men
por: Tahara, Nobuhiro, et al.
Publicado: (2010)

Advanced glycation end products and cognitive impairment in schizophrenia
por: Kobori, Akiko, et al.
Publicado: (2021)

Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis
por: Tanaka, Kenji, et al.
Publicado: (2021)

Evaluation of Relevance between Advanced Glycation End Products and Diabetic Retinopathy Stages Using Skin Autofluorescence
por: Takayanagi, Yuji, et al.
Publicado: (2020)

Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products
por: Ooi, Hayahide, et al.
Publicado: (2022)

Alcohol and Acetaldehyde in Public Health: From Marvel to Menace
por: Guo, Rui, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_aqnv4461vi2csr3f6gn73c9hqp